Advisor Group, Inc. - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$91,000
+62.5%
12,3590.0%0.00%
Q3 2019$56,000
-54.5%
12,3590.0%0.00%
-100.0%
Q2 2019$123,000
+373.1%
12,359
+458.0%
0.00%
Q1 2019$26,000
-3.7%
2,2150.0%0.00%
Q4 2018$27,000
-28.9%
2,2150.0%0.00%
Q3 2018$38,000
-61.6%
2,215
-61.9%
0.00%
-100.0%
Q2 2018$99,0005,8150.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,259,840$2,054,0001.16%
AMERICAN FINANCIAL GROUP INC 1,480,000$2,412,0000.64%
Altium Capital Management LP 1,118,000$1,822,0000.48%
Vanguard Capital Wealth Advisors 437,900$457,0000.31%
Mesirow Financial Investment Management, Inc. 18,894$31,0000.09%
Nantahala Capital Management 1,209,338$1,971,0000.06%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$3,414,0000.05%
Altshuler Shaham Ltd 1,157,540$1,896,0000.01%
Clal Insurance Enterprises Holdings Ltd 585,000$954,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 41,642$68,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders